COVID-19 survivors may have long lasting immunity; Pfizer vaccine is 95% effective in trial


  • World
  • Thursday, 19 Nov 2020

FILE PHOTO: The ultrastructural morphology exhibited by the 2019 Novel Coronavirus (2019-nCoV), which was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China, is seen in an illustration released by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia, U.S. January 29, 2020. Alissa Eckert, MS; Dan Higgins, MAM/CDC/Handout via REUTERS/File Photo

(Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Immune protection against severe reinfection appears lasting

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Timeline: King Charles set to resume duties after cancer treatment
Roundup: Kenya allocates 30 mln USD for flood response as death toll reaches 70
Over 122,000 people enter Ethiopia from conflict-hit Sudan: UN
King Charles to resume public duties after cancer diagnosis
Urgent: Paris 2024 Olympic flame handed over to French organizers
Bird flu traces found in one in five US commercial milk samples, says FDA
South Africa's Climate Change Bill heads to president to be signed into law
South Africa to close Lesotho highlands water tunnels for maintenance
Death toll rises to 70 as heavy rains continue in Kenya
UN provides 5.5 mln USD for drought response in Zambia

Others Also Read